Grant: Discovery Grants Program - Individual
University of Waterloo
$27,000.00
Non-receptor tyrosine kinase regulation of the neuronal cytoskeleton
FY 2010-11
Summary
Abelson kinase (Abl) can cause a form of leukemia in humans and is the target of a very successful drug called Gleevec?. However Abl is also present in the central nervous system. In the brain, Abl and the related gene Arg are important for the development and maintenance of connections between brain cells (neurons). Abl and Arg are crucial for regulating the structure of cells. This project will study and use Abl and other proteins as tools to investigate the basic mechanisms of changing brain cell shape and understanding how these changes affect brain cell function. We will answer fundamental questions about how Abl and related proteins work in neurons, how their activity affects cell to cell connections in the brain, and what his means for neuron function in normal and diseased brains. As our research program progresses we will develop new techniques for monitoring brain cell connectivity and structure.
Our research will help train the next generation of highly-qualified personnel (HQP). The training of these young scientists will take place in a dynamic, collaborative environment. Our HQP will learn a variety of powerful scientific techniques, publish their results, and disseminate their scientific knowledge with fellow Canadian as well as international scientists.
Our research will have a significant impact in several key areas. We will make important contributions to understanding protein-protein interactions and how brain cells communicate with each other. A better understanding of how brain cells communicate will help us learn to design better therapeutic agents will fewer side-effects to treat mental health diseases. A better understanding of brain cell function will also help us understand why some brain cells die while other brain cells survive. Knowledge about cell death and cell survival could be applied in the future to diseases such as stroke or dementia.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
371384-2010
Name nom
Beazely, Michael
Department département
Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5109
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Intra-cellular targeting
Research subject fr
Cibles intra-cellulaires
Partie
1
Nb partie
1
Application title
Non-receptor tyrosine kinase regulation of the neuronal cytoskeleton
Keyword
NSERC
Application summary
Abelson kinase (Abl) can cause a form of leukemia in humans and is the target of a very successful drug called Gleevec?. However Abl is also present in the central nervous system. In the brain, Abl and the related gene Arg are important for the development and maintenance of connections between brain cells (neurons). Abl and Arg are crucial for regulating the structure of cells. This project will study and use Abl and other proteins as tools to investigate the basic mechanisms of changing brain cell shape and understanding how these changes affect brain cell function. We will answer fundamental questions about how Abl and related proteins work in neurons, how their activity affects cell to cell connections in the brain, and what his means for neuron function in normal and diseased brains. As our research program progresses we will develop new techniques for monitoring brain cell connectivity and structure.
Our research will help train the next generation of highly-qualified personnel (HQP). The training of these young scientists will take place in a dynamic, collaborative environment. Our HQP will learn a variety of powerful scientific techniques, publish their results, and disseminate their scientific knowledge with fellow Canadian as well as international scientists.
Our research will have a significant impact in several key areas. We will make important contributions to understanding protein-protein interactions and how brain cells communicate with each other. A better understanding of how brain cells communicate will help us learn to design better therapeutic agents will fewer side-effects to treat mental health diseases. A better understanding of brain cell function will also help us understand why some brain cells die while other brain cells survive. Knowledge about cell death and cell survival could be applied in the future to diseases such as stroke or dementia.